They identified CK19 and CA19-9 as highly sensitive markers for iCCA, and Glypican 3 and Hep Par 1 for HCC, with sensitivities reaching 100% in detecting these cancers. The gene discussed is KRT19; the disease is hepatocellular carcinoma.